Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
M.D. Anderson Cancer Center
Thomas Jefferson University
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Abramson Cancer Center at Penn Medicine
Hoffmann-La Roche
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Istituti Clinici Scientifici Maugeri SpA
University of Southern California
Poitiers University Hospital
Memorial Sloan Kettering Cancer Center
University Hospital Tuebingen
Istituti Clinici Scientifici Maugeri SpA
The Netherlands Cancer Institute
Istituti Clinici Scientifici Maugeri SpA
Institut Curie
Assistance Publique - Hôpitaux de Paris
Wake Forest University Health Sciences
Austrian Breast & Colorectal Cancer Study Group
Washington University School of Medicine
Centre Hospitalier Universitaire de Besancon
Institut de Cancérologie de Lorraine
Institut Curie
Kansas State University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
University of Chicago
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University Medical Center Groningen
Washington University School of Medicine
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle